Works matching IS 10584838 AND DT 2011 AND VI 52 AND IP 9


Results: 33
    1

    Subscription Page.

    Published in:
    Clinical Infectious Diseases, 2011, v. 52, n. 9, p. NP, doi. 10.1093/cid/cir290
    Publication type:
    Article
    2
    3

    Reply to Fazili and Wani.

    Published in:
    2011
    By:
    • Worsøe, Lise;
    • Cayé-Thomasen, Per;
    • Østergaard Andersen, Christian
    Publication type:
    Letter
    4

    Erratum.

    Published in:
    2011
    Publication type:
    Correction Notice
    5
    6
    7

    Erratum.

    Published in:
    2011
    Publication type:
    Correction Notice
    8
    9
    10

    Guidelines for the Prevention of Intravascular Catheter-related Infections.

    Published in:
    Clinical Infectious Diseases, 2011, v. 52, n. 9, p. e162
    By:
    • O'Grady, Naomi P.;
    • Alexander, Mary;
    • Burns, Lillian A.;
    • Dellinger, E. Patchen;
    • Garland, Jeffrey;
    • Heard, Stephen O.;
    • Lipsett, Pamela A.;
    • Masur, Henry;
    • Mermel, Leonard A.;
    • Pearson, Michele L.;
    • Raad, Issam I.;
    • Randolph, Adrienne G.;
    • Rupp, Mark E.;
    • Saint, Sanjay
    Publication type:
    Article
    11
    12
    13

    Erratum.

    Published in:
    2011
    Publication type:
    Correction Notice
    14

    Erratum.

    Published in:
    2011
    Publication type:
    Correction Notice
    15

    Erratum.

    Published in:
    2011
    Publication type:
    Correction Notice
    16
    17
    18

    In the Literature.

    Published in:
    Clinical Infectious Diseases, 2011, v. 52, n. 9, p. iii, doi. 10.1093/cid/cir098
    Publication type:
    Article
    19
    20

    Erratum.

    Published in:
    2011
    Publication type:
    Correction Notice
    21
    22
    23
    24
    25

    Editorial Board.

    Published in:
    Clinical Infectious Diseases, 2011, v. 52, n. 9, p. NP, doi. 10.1093/cid/cir291
    Publication type:
    Article
    26
    27
    28
    29
    30

    News.

    Published in:
    Clinical Infectious Diseases, 2011, v. 52, n. 9, p. i, doi. 10.1093/cid/cir196
    Publication type:
    Article
    31

    Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?

    Published in:
    Clinical Infectious Diseases, 2011, v. 52, n. 9, p. e194, doi. 10.1093/cid/cir184
    By:
    • van Ingen, Jakko;
    • Aarnoutse, Rob E.;
    • Donald, Peter R.;
    • Diacon, Andreas H.;
    • Dawson, Rodney;
    • Plemper van Balen, Georgette;
    • Gillespie, Stephen H.;
    • Boeree, Martin J.
    Publication type:
    Article
    32

    Board of Directors.

    Published in:
    Clinical Infectious Diseases, 2011, v. 52, n. 9, p. NP, doi. 10.1093/cid/cir292
    Publication type:
    Article
    33

    Cover.

    Published in:
    Clinical Infectious Diseases, 2011, v. 52, n. 9, p. NP, doi. 10.1093/cid/cir106
    Publication type:
    Article